- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01523925
Combined Behavioral Approaches With Functional Electrical Therapy in Stroke Rehabilitation
February 10, 2015 updated by: Chang Gung Memorial Hospital
Combined Behavioral Approaches With Functional Electrical Therapy in Stroke Rehabilitation: Effects on Motor Control, Motor Impairment, Daily Function and Community Reintegration
This project attempts to perform a randomized controlled trial to verify the efficacy and motor control mechanism of the proposed combined functional electrical therapy with distributed constraint-induced therapy or with robot-assisted Bilateral training.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
Two theory-based, task-oriented approaches are distributed CIT (dCIT) and robot-assisted Bilateral training(BAT).
CIT/dCIT involves massed practice of the affected arm and restraint of the unaffected arm.
BAT involves repetitive practice of symmetrical bilateral movements on robot.
Both are evident to improve motor performance, motor control or daily function in high functioning patients.
These dCIT and BAT have their own limitations for motor-deficit rehabilitation after stroke, i.e.
only appropriate for high-functioning or mildly motor impaired patients.
Functional electrical therapy, an innovative technology, is proposed as an adjunct to these behavioral approaches to assist in movement execution.
Functional electrical therapy is used to increase the electric activity of muscles for movement and the active range of motion in low functioning patients.
Combining functional electrical therapy into CIT or BAT may extend the utility of these two behavioral approaches beyond patients with mild motor deficits and could expedite the progress of motor recovery.
This project attempts to perform a randomized controlled trial to verify the efficacy and motor control mechanism of the proposed combined functional electrical therapy with dCIT or with BAT.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taoyuan County, Taiwan
- Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The onset duration more than 6 months
- An initial upper extremity subsection of the Fugl-Meyer Assessment score of 33 to 52 indicating moderate or moderate-to-mild movement impairment
- No serious cognitive deficits (a score of more than 24 on the Mini Mental State Exam)
- The availability of caregiver for assistance during the 6-hour restraint time of unaffected extremity per day
- No balance problems sufficient to compromise safety when wearing the project's constraint device with the assistance of the caregiver
- Considerable nonuse of the affected upper extremity (an AOU score < 2.5 of Motor Activity Log)
Exclusion Criteria:
- Exhibit physician determined major medical problems or poor physical conditions that would interfere with participation
- Excessive pain in any joint that might limit participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Combined dCIT with FET
Combined distributed constraint induced therapy with functional electrical therapy
|
This dCIT group focuses on restriction on movement of the unaffected hand by placement of the hand in a mitt for 6 hours/day and intensive training of the affected upper extremity in functional tasks 1.5 hours/weekday, for 4 weeks.
The level of challenge will be adapted based on patient ability and improvement during training.
Patients will be encouraged to initiate the designed therapeutic functional activities.
Other Names:
Other Names:
|
|
Experimental: Combined BAT with FET
Combined bilateral arm treatment with functional electrical therapy
|
Other Names:
The BAT group concentrates on the simultaneous movements of both the affected and unaffected upper extremity on robot for 1.5 hours/day, 5 days/week for 4 weeks.
Other Names:
|
|
Active Comparator: Control intervention group
Control intervention
|
The conventional intervention group is designed to control for the duration and intensity of patient-therapist interactions and therapeutic activities (1.5 hours/day, 5 days/week, for 4 weeks).
Therapy in the control intervention group will involve training for coordination, balance, and movements of the affected upper extremity, as well as compensatory practice on functional tasks with the unaffected upper extremity or both upper extremities.
Other Names:
|
|
Experimental: dCIT
distributed constraint induced therapy
|
This dCIT group focuses on restriction on movement of the unaffected hand by placement of the hand in a mitt for 6 hours/day and intensive training of the affected upper extremity in functional tasks 1.5 hours/weekday, for 4 weeks.
The level of challenge will be adapted based on patient ability and improvement during training.
Patients will be encouraged to initiate the designed therapeutic functional activities.
Other Names:
|
|
Experimental: BAT
bilateral arm treatment
|
The BAT group concentrates on the simultaneous movements of both the affected and unaffected upper extremity on robot for 1.5 hours/day, 5 days/week for 4 weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Movement time (MT)
Time Frame: Baseline and change from baseline in MT at 4 weeks
|
The movement time is collected by a 7-camera motion analysis system (VICON MX 3-D, Oxford Metrics Inc., Oxford, UK) from unilateral and bilateral reaching tasks of pressing the desk bell.
MT is the interval between movement onset and offset.
|
Baseline and change from baseline in MT at 4 weeks
|
|
Total displacement (TD)
Time Frame: Baseline and change from baseline in TD at 4 weeks
|
The movement time is collected by a 7-camera motion analysis system (VICON MX 3-D, Oxford Metrics Inc., Oxford, UK) from unilateral and bilateral reaching tasks of pressing the desk bell.
TD refers to the path of a hand in three-dimensional space and is a measure of trajectory smoothness.
|
Baseline and change from baseline in TD at 4 weeks
|
|
Percentage of peak velocity (PPV)
Time Frame: Baseline and change from baseline in PPV at 4 weeks
|
The movement time is collected by a 7-camera motion analysis system (VICON MX 3-D, Oxford Metrics Inc., Oxford, UK) from unilateral and bilateral reaching tasks of pressing the desk bell.
The PPV reflects the duration of the acceleration phase relative to the deceleration phase and indicates the type of movement strategy selected for a motor action.
|
Baseline and change from baseline in PPV at 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fugl-Meyer Assessment (FMA)
Time Frame: Baseline, change from baseline in FMA at 2 weeks, and change from baseline in FMA at 4 weeks
|
The UE subscale of the FMA (max.
score 66) uses a 3-point ordinal scale to assess motor impairment.
|
Baseline, change from baseline in FMA at 2 weeks, and change from baseline in FMA at 4 weeks
|
|
Motor Activity Log (MAL)
Time Frame: Baseline, change of MAL at 2 weeks, and change of MAL at 4 weeks
|
The MAL is a semi-structured interview of patients to assess the amount of use (AOU) and quality of movement (QOM) of the affected upper extremity in 30 important daily activities using a 6-point ordinal scale.
Higher scores indicate better performance.
|
Baseline, change of MAL at 2 weeks, and change of MAL at 4 weeks
|
|
ABILHAND Questionnaire
Time Frame: Baseline, change of ABILHAND Questionnaire at 2 weeks, and change of ABILHAND Questionnaire at 4 weeks
|
ABILHAND questionnaire is an inventory of 56 manual activities that uses a 3-point ordinal scale to measure subjectively perceived difficulty in performing everyday bimanual activity.
|
Baseline, change of ABILHAND Questionnaire at 2 weeks, and change of ABILHAND Questionnaire at 4 weeks
|
|
Medical Research Council scale (MRC)
Time Frame: Baseline, change from baseline in MRC at 2 weeks, and change from baseline in MRC at 4 weeks
|
The MRC scale examines the muscle strength of the affected arm and is reliable measurement with score ranged from 0 (no contraction) to 5 (normal power).
|
Baseline, change from baseline in MRC at 2 weeks, and change from baseline in MRC at 4 weeks
|
|
Modified Ashworth Scale (MAS)
Time Frame: Baseline, change from baseline in MAS at 2 weeks, and change from baseline in MAS at 4 weeks
|
The MAS scale is an ordinal scale (0-5 points) assessing spasticity of skeletal muscle in UE.
A higher score indicating more spasticity.
|
Baseline, change from baseline in MAS at 2 weeks, and change from baseline in MAS at 4 weeks
|
|
MYOTON-3
Time Frame: Baseline, change from baseline in MYOTON-3 at two weeks, and change from baseline in MYOTON-3 at 4 weeks
|
Assessment of the functional state of skeletal muscle was carried out using myometric measurements with the MYOTON-3 device.
|
Baseline, change from baseline in MYOTON-3 at two weeks, and change from baseline in MYOTON-3 at 4 weeks
|
|
Reintegration of Normal Living Index (RNL)
Time Frame: Baseline, change of RNL at 2 weeks, and change of RNL at 4 weeks
|
The RNL is used to measure the satisfaction with community reintegration.
It scores on a 4-point ordinal scale, with higher scores indicating a higher level of satisfaction.
|
Baseline, change of RNL at 2 weeks, and change of RNL at 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ching-yi Wu, ScD, Chang Gung University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
January 30, 2012
First Submitted That Met QC Criteria
January 30, 2012
First Posted (Estimate)
February 1, 2012
Study Record Updates
Last Update Posted (Estimate)
February 11, 2015
Last Update Submitted That Met QC Criteria
February 10, 2015
Last Verified
September 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NSC 99-2314-B-182-014-MY3
- 98-3827B (Other Identifier: Chang Gung Memorial Hospital)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebrovascular Accident
-
China Medical University HospitalRecruitingCerebrovascular Accident (CVA)Taiwan
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...CompletedStroke | Vascular Accident, Brain | Stroke, Acute | Cerebrovascular Accident | Cerebral Stroke | Cerebrovascular Stroke | Cerebrovascular Accident, Acute | Apoplexy | CVA | Cerebrovascular ApoplexyCanada
-
Sheba Medical CenterCompletedLate Effects of Cerebrovascular Accident
-
Universitaire Ziekenhuizen KU LeuvenCompletedTranscranial Direct Current Stimulation | Cerebrovascular Accident (CVA)Belgium
-
Sunnyview Rehabilitation HospitalCompletedStroke | Stroke, Acute | Cerebrovascular Accident | Cerebrovascular Accident, AcuteUnited States
-
Peking University Third HospitalAstraZeneca Investment (China) Co., LtdCompletedCerebrovascular Accident | Cerebrovascular Accident, AcuteChina
-
Medical University of South CarolinaIcahn School of Medicine at Mount SinaiCompletedIschemic Cerebrovascular AccidentUnited States
-
John DavidsonWashington University School of MedicineWithdrawnIschemic Cerebrovascular AccidentUnited States
-
University of California, IrvineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingStroke, Ischemic | Cerebrovascular Accident (CVA)United States
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
Clinical Trials on dCIT
-
National Taiwan University HospitalUnknownCerebrovascular AccidentTaiwan
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...CompletedCerebrovascular AccidentTaiwan